Gail Roboz, MD from Weill Medical College of Cornell University, New York, NY discusses the standardization of flow cytometry in acute myeloid leukemia (AML). Currently there is a lack of harmonization in ideas of pathologists working with AML. However, Dr Roboz outlines the European Leukemia Nets attempts to create a standardization of techniques to create a worldwide effort to understand what residual detectable populations mean and how much they need to be reduce in order to demonstrate a new therapys efficacy. Recorded at the 2016 Annual Meeting of the British Society of Haematology (BSH) and International Society of Hematology (ISH), in Glasgow, Scotland.
